Genetic alterations in the adenoma–carcinoma sequence

Cancer

Volumn 70, Issue 4 S, 1992, Pages 1727-1731

  Cho, Kathleen R ^a,b   Vogelstein, Bert ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GUANINE NUCLEOTIDE BINDING PROTEIN;

ALLELE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME; CHROMOSOME DELETION; COLORECTAL TUMOR; CONFERENCE PAPER; HUMAN; MODEL; MUTATION; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADENOMA; ALLELES; CARCINOMA; CELL ADHESION MOLECULES; CHROMOSOME DELETION; COLORECTAL NEOPLASMS; GENES, RAS; GENES, TUMOR SUPPRESSOR; HUMAN; MODELS, GENETIC; MUTATION;

EID: 0026648941     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19920915)70:4+<1727::AID-CNCR2820701613>3.0.CO;2-P     Document Type: Article

References (38)

1. A genetic model for colorectal tumorigenesis
2. Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects
3. Clonal analysis of human colorectal tumors
4. Hypomethylation of DNA from benign and malignant human colon neoplasms
5. Prevalence of ras gene mutations in human colorectal cancers
6. Detection of high incidence of K‐ras oncogenes during human colorectal tumorigenesis
7. Genetic alterations during colorectal tumor development
8. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
9. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture
10. Fibroblast immortality is a prerequisite for transformation by EJ c‐Ha‐ras oncogene
11. Cellular oncogenes and multi‐step carcinogenesis
12. Mutations, oncogenes, and cancer
13. Allelotype of colorectal carcinomas
14. Hereditary cancer, oncogenes and antioncogenes
15. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
16. Identification of germline and somatic mutations affecting the retinoblastoma gene
17. Chromosome 17p deletions and p53 gene mutations in colorectal carcinomas
18. Regional mapping panel for human chromosome 17: application to neurofibromatosis type I
19. Cellular immortalization by a cDNA clone encoding the transformation associated phosphoprotein p53
20. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells
21. Cooperation between gene encoding p53 tumour antigen and rus in cellular transformation
22. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene
23. The p53 proto‐oncogene can act as a suppressor of transformation
24. Wild type p53 can inhibit oncogene mediated focus formation
25. Mutations in the p53 gene occur in diverse human tumour types
26. P53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis
27. P53: a frequent target for genetic abnormalities in lung cancer
28. Increased expression of mutant forms of p53 oncogene in primary lung cancer
29. Identification of p53 gene mutations in bladder cancers and urine samples
30. Germline p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms
31. Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18
32. Identification of a chromosome 18q gene which is altered in colorectal cancers
33. Sup‐pression of human colorectal carcinoma cell growth by wild‐type p53
34. Chromosome 5 allele loss in human colorectal carcinomas
35. Localization of the gene for familial adenomatous polyposis on chromosome 5
36. The gene for familial polyposis coli maps to the long arm of chromosome 5
37. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers
38. Distinct sequence elements control the specificity of G protein activation by muscarinic acetylcholine receptor subtypes